Abstract P1-12-16: Efficacy of adjuvant tamoxifen in hormone receptor-positive premenopausal breast cancer patients according to the body mass index

2015 ◽  
Author(s):  
Kadri Altundag ◽  
Mehmet AN Sendur ◽  
Sercan Aksoy ◽  
Taner Babacan ◽  
Yavuz Ozisik
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Cancer Patients ◽  
Body Mass ◽  
Hormone Receptor ◽  
The Body ◽  
Adjuvant Tamoxifen ◽  
Breast Cancer Patients ◽  
Premenopausal Breast Cancer ◽  
Hormone Receptor Positive

Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients

Breast Cancer ◽  
2012 ◽  
Vol 21 (5) ◽  
pp. 557-562 ◽  
Author(s):  
Daisuke Shimizu ◽  
Takashi Ishikawa ◽  
Mikiko Tanabe ◽  
Takeshi Sasaki ◽  
Yasushi Ichikawa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Hormone Receptor ◽  
Breast Cancer Patients ◽  
Premenopausal Breast Cancer ◽  
Hormone Receptor Positive ◽  
Goserelin Acetate

Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients

2020 ◽  
Vol 20 (1) ◽  
pp. e89-e98 ◽  
Author(s):  
Luca Cantini ◽  
Mirco Pistelli ◽  
Filippo Merloni ◽  
Andrea Fontana ◽  
Ilaria Bertolini ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Cancer Patients ◽  
Body Mass ◽  
Early Breast Cancer ◽  
Hormone Receptor ◽  
Recurrence Risk ◽  
Hormone Receptor Status ◽  
Breast Cancer Patients ◽  
Her2 Positive

scholarly journals The prognostic influence of body mass index in premenopausal breast cancer patients

The Breast ◽  
2003 ◽  
Vol 12 ◽  
pp. S18 ◽  
Author(s):  
S. Taucher ◽  
M. Gnant ◽  
H. Hausmaninger ◽  
E. Kubista ◽  
P. Wagner ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Cancer Patients ◽  
Body Mass ◽  
Breast Cancer Patients ◽  
Premenopausal Breast Cancer

The body mass index (BMI) and the effectiveness of the fulvestrant as treatment postmenopausal metastatic breast cancer patients

The Breast ◽  
2019 ◽  
Vol 44 ◽  
pp. S66
Author(s):  
A. Jagiello-Gruszfeld ◽  
I. Lemanska ◽  
A. Gorniak ◽  
M. Kunkiel ◽  
E. Glinka ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Body Mass ◽  
Metastatic Breast ◽  
The Body ◽  
Breast Cancer Patients

Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 512-512 ◽  
Author(s):  
G. Pfeiler ◽  
R. Königsberg ◽  
C. F. Singer ◽  
M. Seifert ◽  
P. C. Dubsky ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Body Mass ◽  
Breast Cancer Patients ◽  
Premenopausal Breast Cancer

scholarly journals PO125 INFLUENCE OF HER2 STATUS ON METASTATIC PATTERN IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT TAMOXIFEN ONLY

The Breast ◽  
2013 ◽  
Vol 22 ◽  
pp. S62
Author(s):  
Ivana Bozovic Spasojevic ◽  
Snezana Susnjar ◽  
Marijana Milovic Kovacevic ◽  
Zora Neskovic Konstatinovic ◽  
Tijana Vujasinovic ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Hormone Receptor ◽  
Adjuvant Tamoxifen ◽  
Her2 Status ◽  
Breast Cancer Patients ◽  
Postmenopausal Hormone ◽  
Metastatic Pattern ◽  
Hormone Receptor Positive ◽  
Positive Breast Cancer

Prognostic significance of body mass index in breast cancer patients with hormone receptor-positive tumours after curative surgery

2013 ◽  
Vol 36 (6) ◽  
pp. 297 ◽  
Author(s):  
Peng Xing ◽  
Ji-Guang Li ◽  
Feng Jin ◽  
Ting-Ting Zhao ◽  
Qun Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Body Mass ◽  
Hormone Receptor ◽  
Univariate Analysis ◽  
Prognostic Significance ◽  
Axillary Lymph ◽  
Nodal Stage ◽  
Hormone Receptor Positive ◽  
High Bmi

Purpose: Obesity has been recognized as a significant risk factor for postmenopausal breast cancer. The aim of this study is to investigate the prognostic significance of body mass index (BMI) in hormone receptor-positive, operable breast cancer. Methods: In this retrospective cohort study, 1,192 consecutive patients with curative resection of primary breast cancer were enrolled. Patients were assigned to two groups according to BMI: normal or underweight (BMI < 23.0 kg/m2) and overweight or obese (BMI ≥23.0 kg/m2). Associations among BMI and clinicopathological characteristics and prognosis of patients were assessed. Results: A high BMI was significantly (P < 0.01) correlated with age, nodal stage, ALNR, ER positivity, PR positivity and menopausal status at diagnosis. Univariate analysis revealed that BMI, pathologic T stage, nodal stage, axillary lymph node ratio (ALNR) and adjuvant radiotherapy history were significantly (P < 0.05) associated with disease-free survival and overall survival, irrespective of tumour hormone receptor status. Multivariate analysis revealed BMI as an independent prognostic factor in all cases and in hormone receptor-positive cases. Conclusion: A high BMI (≥23.0 kg/m^2) is independently associated with poor prognosis in hormone receptor-positive breast cancer.

Sign in / Sign up

Export Citation Format

Share Document